| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |